APA (7th ed.) Citation

Arimidex, T. A. o. i. C. T. G., Baum, M., Budzar, A. U., Cuzick, J., Forbes, J., Houghton, J. H., . . . Group, A. T. (2002). Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: First results of the ATAC randomised trial. Lancet, 359(9324), 2131. https://doi.org/10.1016/s0140-6736(02)09088-8

Chicago Style (17th ed.) Citation

Arimidex, Tamoxifen Alone or in Combination Trialists' Group, M. Baum, A U. Budzar, J. Cuzick, J. Forbes, J H. Houghton, J G M. Klijn, T. Sahmoud, and ATAC Trialists' Group. "Anastrozole Alone or in Combination with Tamoxifen Versus Tamoxifen Alone for Adjuvant Treatment of Postmenopausal Women with Early Breast Cancer: First Results of the ATAC Randomised Trial." Lancet 359, no. 9324 (2002): 2131. https://doi.org/10.1016/s0140-6736(02)09088-8.

MLA (9th ed.) Citation

Arimidex, Tamoxifen Alone or in Combination Trialists' Group, et al. "Anastrozole Alone or in Combination with Tamoxifen Versus Tamoxifen Alone for Adjuvant Treatment of Postmenopausal Women with Early Breast Cancer: First Results of the ATAC Randomised Trial." Lancet, vol. 359, no. 9324, 2002, p. 2131, https://doi.org/10.1016/s0140-6736(02)09088-8.